To assess the total Treg population in RA patients, we defined Treg cells using molecular markers such as CD25, CD127, or Foxp3 and analyzed their proportion among CD4+ T cells in the peripheral blood of RA patients and healthy donors (Figure 1A) [46,47]. Here, CD4 is linked to rheumatoid arthritis.